The prognosis of gliomas with different molecular subtypes in the era of intensity-modulated radiation therapy (IMRT)

Qiulu Zhong; Danjing Luo; Da Chen; Xiangde Li; Qinghua Du; Qianfu Liang; Jian Li; Xiaodong Zhu

doi:doi:10.18632/aging.204942

← Back

Research Paper Volume 15, Issue 15 pp 7781—7793

The prognosis of gliomas with different molecular subtypes in the era of intensity-modulated radiation therapy (IMRT)

Figure 2. Kaplan-Meier curve for overall survival for gliomas with different IDH status. There is no statistically significant difference in IDH-mut group and IDH-wild group.